Drug information for RABEPRAZOLE
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
TABLET, DELAYED RELEASE; ORAL
20MG
Tentative Approval
RABEPRAZOLE SODIUM
rabeprazole
MYLAN PHARMA
76885
2006-01-20 Letter
Drug Adverse Effects information for RABEPRAZOLE
Role code
Indications
Reaction
# Reports
C
ANGINA PECTORIS
INTERSTITIAL LUNG DISEASE
3
C
ANGINA PECTORIS
RENAL IMPAIRMENT
3
C
ARTHRITIS
CATARACT OPERATION
1
C
BLOOD CHOLESTEROL
CATARACT
2
C
BLOOD CHOLESTEROL
LASER THERAPY
2
C
BLOOD CHOLESTEROL
VISUAL ACUITY REDUCED
2
C
BLOOD PRESSURE
CATARACT
2
C
BLOOD PRESSURE
LASER THERAPY
2
C
BLOOD PRESSURE
VISUAL ACUITY REDUCED
2
C
BRAIN OEDEMA
INTERSTITIAL LUNG DISEASE
1
C
BRAIN OEDEMA
RENAL IMPAIRMENT
1
C
DIABETES MELLITUS
CATARACT
2
C
DIABETES MELLITUS
INTERSTITIAL LUNG DISEASE
2
C
DIABETES MELLITUS
LASER THERAPY
2
C
DIABETES MELLITUS
RENAL IMPAIRMENT
2
C
DIABETES MELLITUS
VISUAL ACUITY REDUCED
2
C
DYSPEPSIA
CATARACT
2
C
DYSPEPSIA
LASER THERAPY
2
C
DYSPEPSIA
VISUAL ACUITY REDUCED
2
C
GASTRIC ULCER
INTERSTITIAL LUNG DISEASE
2
C
GASTRIC ULCER
RENAL IMPAIRMENT
2
C
GASTROOESOPHAGEAL REFLUX DISEASE
CATARACT OPERATION
1
C
GLAUCOMA
CATARACT
3
C
GLAUCOMA
CATARACT OPERATION
1
C
GLAUCOMA
INTRAOCULAR PRESSURE INCREASED
2
C
GLAUCOMA
LASER THERAPY
1
C
GLAUCOMA
VISUAL ACUITY REDUCED
1
C
HYPERLIPIDAEMIA
INTERSTITIAL LUNG DISEASE
1
C
HYPERLIPIDAEMIA
RENAL IMPAIRMENT
1
C
HYPERTENSION
INTERSTITIAL LUNG DISEASE
1
C
HYPERTENSION
RENAL IMPAIRMENT
1
C
INSOMNIA
INTERSTITIAL LUNG DISEASE
1
C
INSOMNIA
RENAL IMPAIRMENT
1
C
MACULAR DEGENERATION
CATARACT
2
C
MACULAR DEGENERATION
LASER THERAPY
2
C
MACULAR DEGENERATION
VISUAL ACUITY REDUCED
2
C
OPEN ANGLE GLAUCOMA
CATARACT
1
C
OPEN ANGLE GLAUCOMA
LASER THERAPY
1
C
OPEN ANGLE GLAUCOMA
VISUAL ACUITY REDUCED
1
C
RENAL CELL CARCINOMA
INTERSTITIAL LUNG DISEASE
2
C
RENAL CELL CARCINOMA
RENAL IMPAIRMENT
2
Ads by Google